openPR Logo
Press release

Conjugate Vaccines Market to Garner Brimming Revenues by 2023: Novartis, Neuron Biotech, Serum

02-14-2019 11:18 AM CET | Health & Medicine

Press release from: Allied Market Research

/ PR Agency: Allied Market Research
Conjugate Vaccines Market to Garner Brimming Revenues by 2023:

Conjugated vaccines refer to vaccines containing bacterial capsule polysaccharides or antigen bound or conjugated to a protein. This protein has a key role in improving the immunogenic property of the polysaccharide. These vaccines are mainly used to immunize infants and children against invasive diseases caused by Hib bacteria, H. influenzae, Streptococcus pneumoniae and Neisseria meningitidis.

The increase in the use of conjugate vaccines for adults, the increase in the number of regulatory approvals for conjugated vaccines, the growth in the prevalence of diseases caused by microorganisms such as Streptococcus pneumoniae and Neisseria meningitidis, and technological advances drive market growth. In contrast, low accessibility to vaccines in remote areas and the complex production procedure of the conjugate vaccine restrict market growth.

Get Access to TOC / Sample Report @ https://www.alliedmarketresearch.com/request-toc-and-sample/2891?utm_source=openpr_ss

Major Market Players:

• Novartis AG
• Neuron Biotech
• Serum Institute of India
• Pfizer Inc.
• Sanofi Pasteur
• Bharat Biotech
• Biological E
• GlaxoSmithKline Plc.
• Merck and Company

This report segments the market according to the type, the indication of disease, the type of pathogen, the end user and the region. Based on the type, the market bifurcates in monovalent conjugate vaccines and multivalent conjugate vaccines. According to the indication of the disease, it is classified as pneumococcal, influenza, diphtheria and whooping cough (DTP), meningococcal and others.

Send Enquiry on this Report @ https://www.alliedmarketresearch.com/purchase-enquiry/2891?utm_source=openpr_ss

Depending on the type of pathogen, it is classified into bacterial conjugate vaccine, viral conjugate vaccine and combined conjugate vaccine (viral and bacterial). Based on the end user, the market is segmented into pediatrics and adults. By geography, it is analyzed in North America, Europe, Asia-Pacific and LAMEA.

Key Benefits of Conjugate Vaccines Market:

• The study provides an in-depth analysis of the world market for conjugate vaccines, with current trends and future estimates to elucidate imminent investment pockets.

• It presents a quantitative analysis from 2016 to 2023 to allow interested parties to capitalize on prevailing market opportunities.

• An extensive analysis of the market by type of product helps to understand the various forms of conjugate vaccine available.

• The key players are profiled and their strategies are analyzed in depth, which predicts the competitive perspective of the market.

Browse More Details of Report @ https://www.alliedmarketresearch.com/conjugate-vaccines-market?utm_source=openpr_ss

About Us:

Allied Market Research, a market research and advisory company of Allied Analytics LLP, provides business insights and market research reports to large as well as small & medium enterprises. The company assists its clients to strategize business policies and achieve sustainable growth in their respective market domain.
Allied Market Research provides one stop solution from the beginning of data collection to investment advice. The analysts at Allied Market Research dig out factors that help clients to understand the significance and impact of market dynamics. The company amplies client’s insight on the factors, such as strategies, future estimations, growth or fall forecasting, opportunity analysis, and consumer surveys among others. As follows, the company offers consistent business intelligent support to aid the clients to turn into prominent business firm.

Contact:

David Correa
5933 NE Win Sivers Drive
#205, Portland, OR 97220
United States
Toll Free (USA/Canada):
+1-800-792-5285, +1-503-894-6022, +1-503-446-1141
UK: +44-845-528-1300
Hong Kong: +852-301-84916
India (Pune): +91-20-66346060
Fax: +1⟨855⟩550-5975
help@alliedmarketresearch.com
Web: https://www.alliedmarketresearch.com

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Conjugate Vaccines Market to Garner Brimming Revenues by 2023: Novartis, Neuron Biotech, Serum here

News-ID: 1588124 • Views: 220

More Releases from Allied Market Research

North America Geogrid Market 2020 Segmentation, Demand, Growth, Trend, Opportuni …
According to the report published by Allied Market Research, the North America geogrid market generated $282.0 million in 2019, and is estimated to reach $408.25 million by 2027, registering a CAGR of 7.0% from 2020 to 2027. The report offers an extensive analysis of changing market dynamics, key winning strategies, business performance, major segments, and competitive scenarios. Surge in infrastructure development activities across the U.S. and Mexico and superior physical properties
Intravenous Immunoglobulin (IVIG) Market 2020 In-Depth Analysis of Industry Shar …
Global intravenous immunoglobulin market accounted for $8,995 million in 2017, and is projected to reach $15,964 million by 2025, registering a CAGR of 7.5% from 2018 to 2025. Immunoglobulin (Ig) is a plasma-derived product, which is obtained from the serum of healthy donors. The isolated plasma product is clinically treated and purified to Ig, which can be further used in the treatment of patients with antibody deficiency. Intravenous immunoglobulin (IVIG) finds
Asthma and COPD Drugs Market Is Expected to Witness a Steady Growth by 2026
"Asthma and COPD Drugs Market by Disease and Medication Class - Global Opportunity Analysis and Industry Forecasts, 2014-2022", projects that the global market for Asthma and COPD Drugs was valued at $38,960 million in 2015 and would reach $50,359 million by 2022, registering a CAGR of 3.7% from 2016 to 2022. Asthma segment dominated the market in 2015 and expected to continue its dominance throughout the forecast period. North America
Synthetic Biology Market in Global Industry by Top Companies, Type and Applicati …
Global Synthetic biology market is forecast to reach $38.7 billion by 2020, at a CAGR of 44.2% during the forecast period (2014 - 2020). Europe occupies largest share in the global market and would hold-on to its position throughout 2020. However, Asia Pacific is the fastest growing market with a CAGR of 46.4% from 2014 - 2020. Read Full Report @ https://www.alliedmarketresearch.com/synthetic-biology-market Synthetic biology is at a nascent stage and has recently

All 5 Releases


More Releases for Conjugate

Global Conjugate Vaccine Market Research and Forecast, 2018-2023
Global conjugate vaccine market size, market intelligence, market trends, research and analysis report by product (multivalent, monovalent) by disease (meningococcal, diphtheria tetanus pertussis, influenza, pneumococcal) forecast 2018-2023 According to the OMR analysis, the global conjugate vaccine market is growing at a significant CAGR during 2018-2023. The global conjugate vaccine market has witnessed a significant growth due to government initiatives towards development and awareness of conjugate vaccines and longer immunity and better
Vaccine Conjugate Market Forecast by 2025: QY Research
This report studies the Vaccine Conjugate market size (value and volume) by players, regions, product types and end industries, history data 2013-2017 and forecast data 2018-2025; This report also studies the global market competition landscape, market drivers and trends, opportunities and challenges, risks and entry barriers, sales channels, distributors and Porter's Five Forces Analysis. The global Vaccine Conjugate market was million US$ in 2017 and is expected to million US$ by
Landscape Of The China Conjugate Vaccine Market Outlook: Ken Research
The conjugate vaccine is a type of vaccine that comprises a bacterial capsular polysaccharide, committed to a protein to improve immunogenicity and safeguard against invasive diseases. Moreover, conjugate vaccines association a weak antigen with a strong antigen so that the immune system has a stronger response to the weak antigen. Vaccines are used to avert diseases by appealing an immune response to an antigen, the foreign part of a bacteria
Conjugate Vaccine Market Share, Size & Research Report 2018-2023
Global Conjugate Vaccine Industry New Study On “2018-2023 Conjugate Vaccine Market Global Key Player, Demand, Growth, Opportunities And Analysis Forecast” Added To Wise Guy Reports Database The global conjugate vaccine market is anticipated to grow with the CAGR of 13.4% during the forecast period 2018-2023. Conjugate vaccines are similar to recombinant vaccines manufactured by the combination of two different components. Conjugate vaccines, however, are made by pieces from the coats of bacteria.
Vaccine Conjugate Market Report 2017 - 2022
About Vaccine Conjugate View Entire Report @ https://www.reportsandmarkets.com/reports/emea-europe-middle-east-and-africa-vaccine-conjugate-market-report-2017-1622925 Geographically, this report split EMEA into Europe, the Middle East and Africa, With sales (K MT), revenue (Million USD), market share and growth rate of Vaccine Conjugate for these regions, from 2012 to 2022 (forecast) Europe: Germany, France, UK, Russia, Italy and Benelux; Middle East: Saudi Arabia, Israel, UAE and Iran; Africa: South Africa, Nigeria, Egypt and Algeria. Request for Sample of Premium Research Report with TOC @
Antibody Drug Conjugate Market Opportunity Analysis
Ever since the first attempt in the 1980's to use antibody-based drugs as therapeutic agents, the application and use of monoclonal antibody-drug conjugates has evolved in several ways. The major advantage of using Antibody Drug Conjugates (ADC) is that it brings together the best characteristics of both antibodies and the cytotoxic potential of chemotherapy. This offers significant opportunity for the future in terms of targeted accumulation of drug in the